Divergent Pseudomonas aeruginosa LpxO enzymes perform site-specific lipid A 2-hydroxylation
mBio · 2024
DOI: 10.1128/mbio.02823-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Casey E Hofstaedter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis, University of Maryland, Baltimore, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas Infections, Dioxygenases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Pseudomonas aeruginosa is an opportunistic pathogen that causes severe infection in hospitalized and chronically ill individuals. During infection, P. aeruginosa undergoes adaptive changes to evade host defenses and therapeutic interventions, increasing mortality and morbidity. Lipid A structural alteration is one such change that P. aeruginosa isolates undergo during chronic lung infection in CF. Investigating genetic drivers of this lipid A structural variation is crucial in understanding P. aeruginosa adaptation during infection. Here, we describe two lipid A dioxygenases with acyl-chain site specificity, each with different evolutionary origins. Further, we show that loss of function in these enzymes occurs in CF clinical isolates, suggesting a potential pathoadaptive phenotype. Studying these bacterial adaptations provides insight into selection pressures of the CF airway on P. aeruginosa phenotypes that persist during chronic infection. Understanding these adaptive changes may ultimately provide clinicians better control over bacterial populations during chronic infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Pathogenesis, University of Maryland, Baltimore, Baltimore, Maryland, USA.
- Medical Scientist Training Program, University of Maryland, Baltimore, Baltimore, Maryland, USA.
- Department of Microbiology and Immunology, University of Maryland Baltimore, Baltimore, Maryland, USA.
- Departments of Biochemistry and Microbiology, University of Victoria, Victoria, Canada.
- Institute for Genome Sciences, University of Maryland, Baltimore, Baltimore, Maryland, USA.
- Center for Pathogen Research, University of Maryland, Baltimore, Baltimore, Maryland, USA.
ORCID-Profile: Casey E Hofstaedter, Joseph J Gillespie, Janette M Harro, David A Rasko, Robert K Ernst
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Cystic Fibrosis Foundation
Zitieren
APA
Hofstaedter, C. E., Chandler, C. E., Met, C. M., Gillespie, J. J., Harro, J. M., Goodlett, D. R., Rasko, D. A., & Ernst, R. K. (2024). Divergent Pseudomonas aeruginosa LpxO enzymes perform site-specific lipid A 2-hydroxylation. mBio. https://doi.org/10.1128/mbio.02823-23
Vancouver
Hofstaedter CE, Chandler CE, Met CM, Gillespie JJ, Harro JM, Goodlett DR, et al. Divergent Pseudomonas aeruginosa LpxO enzymes perform site-specific lipid A 2-hydroxylation. mBio. 2024. doi:10.1128/mbio.02823-23
BibTeX
@article{Hofstaedter2024,
author = {Hofstaedter, Casey E and Chandler, Courtney E and Met, Charles M and Gillespie, Joseph J and Harro, Janette M and Goodlett, David R and Rasko, David A and Ernst, Robert K},
title = {Divergent Pseudomonas aeruginosa LpxO enzymes perform site-specific lipid A 2-hydroxylation},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.02823-23}
}
EUVIMED